Corvus Pharmaceuticals, Inc. (CRVS) 8-K Summary
Date of Event: November 4, 2025
Corvus Pharmaceuticals filed an 8-K reporting the release of its financial results covering the three and nine months ended September 30, 2025, and provided a business update via press release (Exhibit 99.1).
- Key Event: Release of Q3 2025 financial performance and position as of September 30, 2025.
- Investor Action: Investors must review Exhibit 99.1 for specific financial metrics, operational highlights, and forward-looking guidance.
- Filing Status: The information furnished